Current role and affiliations
Kristine Aasebø has been a member of the K.G. Jebsen Academy for Young Medical Researchers since 2026. She is a researcher at the K.G. Jebsen Center for Epimutations in Cancer at the University of Bergen (UiB). She is an oncologist at the Cancer Clinic, Haukeland University Hospital, and serves as a clinical oncology advisor at the Norwegian National Molecular Tumor Boards (InPreD).
She obtained her PhD from UiB in 2021, focusing on real-world data regarding the presence and effect of tumor biomarkers in patients with metastatic colorectal cancer. She has been the local principal investigator (PI) for several clinical trials and is part of the core team behind the design and implementation of a national biomarker-guided trial for patients with cancer of unknown primary (CUP). Since 2026, she has held a postdoctoral research position at the Cancer Clinic, where she studies the presence and impact of epigenetic alterations in early-onset colorectal cancer.
Research interests and focus
- Epigenetic mechanisms in colorectal cancer
- Constitutional epimutations and cancer susceptibility
- Early-onset colorectal cancer
- Real-world data in cancer research
- Risk assessment and personalized diagnostics, treatment, and surveillance in colorectal cancer
- Biomarkers and precision oncology for cancer diagnosis and treatment
- Application of biomarkers in clinical trials